Celebrating HIV Research and Results: Treatment as Prevention®

This event, as part of UBC’s Centennial celebrations, is open to the public and will highlight how the implementation of the Treatment as Prevention® (TasP®) strategy has saved lives and changed how we treat HIV – in Canada and around the world.

Celebrating HIV Research and Results will feature a plenary talk, panel sessions, and poster presentations. Hear from community representatives and some of the most influential researchers in the fields of medicine, addiction, HIV/AIDS, including the Director of the BC-CfE and Head of UBC Division of AIDS, Dr. Julio Montaner, and Dr. Evan Wood, and Dr. Rolando Barrios to name a few.

This event is free of charge. A light lunch will be provided. Please note that seating is limited.

For more information, please contact:
Stephanie Donovan
Research Assistant
Phone: (604) 682-2344 ext. 66888
E-mail: sdonovan@cfenet.ubc.ca



Program

10 AM — 10:10 AM Welcome
10:10 AM — 10:55 AM Treatment as Prevention® Plenary
Cullen Family Lecture Theatre, Providence Level 1

Dr. Julio Montaner

10:55 AM — 11:05 AM Break
11:05 AM — 11:50 AM Addressing HIV/AIDS in vulnerable populations: Lessons learned
Cullen Family Lecture Theatre, Providence Level 1

Moderator: Marianne Harris

Panelists:
Dr. Evan Wood
Dr. Kate Shannon
Dr. Rolando Barrios
Dr. Nathan Lachowsky
Tracey Morrison, WAHRS
Hugh Lampkin, VANDU

11:50 AM — 12:30 PM Lunch
12:30 PM— 1:15 PM Exporting Treatment as Prevention®
Cullen Family Lecture Theatre, Providence Level 1

Moderator: Dr. Marianne Harris

Panelists:
Dr. Bob Hogg
Dr. Richard Lester
Dr. Mark Hull
Dr. Mel Krajden

1:15 PM — 1:30 PM Summary remarks

Dr. Julio Montaner

1:30 PM — 3 PM Poster viewing
Main hallway of SPH Conference Centre, Providence Level 1


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below